compounded semaglutide ban update 🚨 FDA Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these What possible compounded semaglutide ban

Injectables: Typically taken weekly and requires refrigeration

Behavior scientists like BJ Fogg have said the reward is meant to release dopamine in the brain so the brain associates it with the habit

PMID: [25415472] REFERENCES National Center for Biotechnology Information

These findings indicate that: Members in Omadas Enhanced GLP-1 Care Track showed higher average medication persistence rates through 24 weeks compared to other real-world evidence Those who persisted saw an average of 11% weight loss with semaglutide and 13% with tirzepatide, outcomes similar to what has been shown in clinical trials Providing the right kind of support to enable people to persist with their GLP-1 medication use long enough to see benefits can help them achieve clinical trial-level weight loss, setting the stage for cardiometabolic disease risk reduction

Dosage: Higher doses (1200mg vs 600mg) and premium formulations cost more

Semin Arthritis Rheum